Clinicians have been centrally important to the success of ESTRO and have served at the highest level on the Society’s Board, councils and committees together with a wide range of ad hoc groups advising on many issues ranging from the very successful annual scientific meetings to the expanding spectrum of teaching courses.

Recognising the wide range of special and occasionally unique issues that are increasingly important to clinicians, the ESTRO Board decided to appoint the first Clinical Committee in 2007.

The committee endeavours to explore a wide range of existing day to day issues together with emerging strategic issues relevant to radiation oncologists as members of the Society. The critical role of research and the development of mechanisms that enable and support evidence-based multidisciplinary treatment approaches for patients and their families are central to the committee’s thinking and strategic goals.  Since its inception, the committee has initiated wide-ranging discussions on a number of major thematic areas of interest to ESTRO clinicians together with areas of potential concern or uncertainty. 

Chair: Maximilian Niyazi, Radiation Oncologist, Tübingen University Hospital (DE) 

Breast FG Chair: Sofia Rivera, Radiation Oncologist, Institut Gustave Roussy (FR)

Children & TYA FG Chair: Anne Laprie, Radiation Oncologist, Toulouse Oncopole University Cancer Institute and Toulouse III University (FR)

Gynaecology FG Chair: Remi Nout, Radiation Oncologist, Erasmus Medical Centre Rotterdam (NL)

Haemato-Oncology FG Chair: Umberto Ricardi, University of Torino (IT)

Head & Neck FG Chair: Jon Cacicedo, Radiation Oncologist, Cruces University Hospital (ES)

Lower GI FG Chair: Pierfrancesco Franco, Radiation Oncologist, University of Turin (IT)

Lung FG Chair: Corinne Faivre-Finn, Clinical Oncologist, University of Manchester (UK)

Oligometastatic Disease FG Chair: Jonas Willmann, Radiation Oncology, University Hospital Zurich (CH)

Skin & Soft Tissue FG Co-Chair: Agata Rembielak, Clinical Oncologist, The University of Manchester and The Christie NHS Foundation Trust (UK)

Systemic Therapy FG Chair: Andrea Filippi, Radiation Oncologist, Instituto Nazionale Tumori and University of Milan (IT)

Upper GI FG Chair: Thomas Brunner, Radiation Oncologist, Medical University of Graz (AT)

Urology FG Chair: Piet Ost, Radiation Oncologist, Iridium Network, GZA Ziekenhuizen (BE)

 

The committee is contactable at  clinical@estro.org 

 

Past Chairs:

Karin Haustermans, Leuven, Belgium

Daniel Zips, Berlin, Germany

Donal Hollywood, Dublin, Ireland